Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia

NCT05724810 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT05724810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05724810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia
Lead sponsor
Stony Brook University
Phase
Not applicable
Overall status
Terminated
Start date
April 4, 2023
Completion date
August 31, 2025
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia, smoking cessation, tobacco use